MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$185,498
Free Cash flow
-$489,502
Unit: Dollar
Positive Cash Flow Breakdown
Net proceeds from notes payable ...
Accounts payable
Non-cash interest expense
Others
Negative Cash Flow Breakdown
Accounts receivable, net
Purchases of property and equipm...
Deferred revenue
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-277,601
-618,466
-578,480
-537,919
Depreciation expense
26,198
22,256
23,912
23,148
Stock-based compensation
41,490
23,527
23,527
19,915
Non-cash interest expense
113,910
174,635
-
-
Provision for credit losses
0
0
50,000
28,876
Provision for inventory obsolescence
0
0
10,252
0
Vendor expense settled in shares
21,000
18,000
18,000
18,000
Gain on settlement of accounts payable
-
-
0
-
Amortization of operating lease right of use assets
19,402
18,942
18,498
18,073
Accounts receivable, net
293,902
312,002
-40,585
360,688
Inventory, net
20,981
34,776
22,386
35,811
Prepaid expenses and other current assets
-27,187
78,699
-38,468
43,307
Accounts payable
177,865
-50,848
-55,576
178,775
Accrued expenses
25,757
99,497
102,900
76,338
Deferred revenue
-77,941
-27,941
-75,000
-75,000
Operating lease liabilities
-18,859
-18,397
-17,346
-16,916
Net cash provided by (used in) operating activities
-236,475
-784,272
-422,646
-706,516
Purchases of property and equipment
253,027
847
43,205
0
Net cash used in investing activities
-253,027
-847
-43,205
0
Net proceeds from issuance of common stock
-
-
0
791,418
Net proceeds from option exercises
-
-
0
113,541
Net proceeds from note payable issuance related party-Nonrelated Party
-
-
300,000
-
Net proceeds from note payable issuance related party-Related Party
-
-
200,000
-
Net proceeds from warrant exercise
-
-
0
0
Net proceeds from notes payable issuance
675,000
500,000
-
-
Net cash provided by financing activities
675,000
500,000
500,000
904,959
Net increase (decrease) in cash
185,498
-285,119
34,149
198,443
Cash, beginning of period
263,827
548,946
514,797
283,714
Cash, end of period
449,325
263,827
548,946
514,797
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net proceeds from
notes payable...
$675,000
Net cash provided by
financing activities
$675,000
Net increase
(decrease) in cash
$185,498
(468.31%↑ Y/Y)
Canceled cashflow
$489,502
Accounts payable
$177,865
(89.84%↑ Y/Y)
Non-cash interest
expense
$113,910
Stock-based compensation
$41,490
(-2.48%↓ Y/Y)
Prepaid expenses and
other current assets
-$27,187
(74.95%↑ Y/Y)
Depreciation expense
$26,198
(-31.78%↓ Y/Y)
Accrued expenses
$25,757
(16.26%↑ Y/Y)
Vendor expense settled
in shares
$21,000
(40.00%↑ Y/Y)
Amortization of operating
lease right of use...
$19,402
(-44.41%↓ Y/Y)
Net cash used in
investing activities
-$253,027
(-9.27%↓ Y/Y)
Net cash provided by
(used in) operating...
-$236,475
(-189.51%↓ Y/Y)
Canceled cashflow
$452,809
Purchases of property and
equipment
$253,027
(9.27%↑ Y/Y)
Accounts receivable, net
$293,902
(246.75%↑ Y/Y)
Net loss
-$277,601
(80.11%↑ Y/Y)
Deferred revenue
-$77,941
(-105.47%↓ Y/Y)
Inventory, net
$20,981
(-14.34%↓ Y/Y)
Operating lease
liabilities
-$18,859
(42.15%↑ Y/Y)
Buy us a coffee
Nuo Therapeutics, Inc. (AURX)
Nuo Therapeutics, Inc. (AURX)